Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients

NCT00481390 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00481390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2007
Enrollment
1,110 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, hiv-1 infection, infection, human immunodeficiency virus i